查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954671

全球蒸氣和過氧化氫滅菌用生物指示劑市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034）

Steam and Hydrogen Peroxide Biological Indicators Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 請詢問到貨日

價格

蒸氣和過氧化氫滅菌用生物指示劑市場成長驅動因素

2025年全球蒸汽和過氧化氫滅菌用生物指示劑市場規模為8.0376億美元，2026年增長至8.6502億美元，預計到2034年將達到16.4403億美元。 2026年至2034年的複合年增長率為8.36%。 北美地區在全球市場中佔領先地位，預計到2025年將佔34.90%的市場佔有率，這主要得益於嚴格的感染控制法規、外科手術數量的增加以及醫療和製藥行業對滅菌監測方案的快速採用。美國市場預計到2030年將達到3.877億美元，這主要受手術部位感染增加以及醫院和牙科診所對滅菌日益重視的推動。 市場概覽與產品分析 生物指示劑（BI）可直接測量使用蒸氣、過氧化氫、環氧乙烷和其他滅菌劑的滅菌過程的滅菌效果，從而確保可靠的監測。醫療機構、製藥、生物技術和食品產業對滅菌的日益重視正在推動市場成長。強制要求預防污染的監管標準以及新產品的推出，進一步加速了生物指示劑在蒸氣和過氧化氫滅菌中的應用。 依產品類型劃分，自封式小瓶（SCBI）憑藉其高可靠性、易用性和快速出結果等優勢，佔最大的市場佔有率。預計到2026年，自封式小瓶市佔率將達到67.33%（價值5.824億美元），主要得益於已開發醫療市場和新興醫療市場對其應用的日益普及。孢子試紙條因其成本低廉且適用於小型診所和醫療機構，佔了第二大市場佔有率。孢子懸浮指示劑也有應用，但市佔率較小。

應用洞察

依應用領域劃分，醫療機構預計到2026年將佔全球市場72.26%的佔有率，成為最大的細分市場，市場規模達6.251億美元。醫院感染（HAI）的增加和外科手術的增多，使得定期進行消毒監測至關重要。 製藥和醫療器材製造商佔第二大市場佔有率，這凸顯了生物指標在其生產流程中的重要性，因為嚴格的滅菌要求可以防止污染和產品召回。

新冠疫情的影響

新冠疫情加速了對滅菌和消毒監測產品的需求。醫院、牙科診所和製藥公司加強了滅菌措施，以防止病毒和細菌引起的醫院感染。例如，3M醫療解決方案部門2020年的收入成長了25.9%，反映了疫情期間對生物指標（BI）需求的成長。雖然疫情後的成長已趨於正常，但持續的外科手術和加強的感染控制方案意味著長期需求仍然強勁。

市場趨勢

市場正在轉向快速生物指標（Rapid BI），其比傳統產品提供更快的檢測結果。 傳統指示劑需要 72 至 168 小時的培養時間，而快速生物指示劑可在數分鐘內提供結果。監管機構的批准，例如美國 FDA 於 2020 年 1 月批准 Sterrad Velocity 生物指示劑，正在推動這一趨勢，並擴大其在製藥和醫療器材製造業的應用。 市場成長驅動因素：

外科手術數量的增加、慢性病盛行率的上升以及醫療保健成本的上漲，正在推動對無菌醫療器材的需求。根據世界衛生組織 (WHO) 統計，全球每年約進行 3.13 億例手術，因此對監測設備（包括用於蒸汽和過氧化氫滅菌的生物指示劑）的需求顯著增長。產品創新，例如 2020 年 12 月推出的 STERIS Spordex SCBI 安瓿，正在進一步促進市場成長。

限制因素：

生物指示劑 (BI) 的應用面臨著來自酶指示劑等替代方案的競爭，後者俱有檢測速度更快、使用更便捷、成本更低等優勢。生物指示劑的高成本也限制了其應用，尤其是在發展中地區。例如，True Indicating LLC 的 Instant 20s 酶指示劑於 2021 年 12 月獲得 FDA 批准，能夠快速監測蒸汽滅菌過程，並對傳統的商業智慧 (BI) 提出了挑戰。

區域洞察

預計到 2025 年，北美將以 2.809 億美元的市場規模引領市場，美國市場預計到 2026 年將達到 2.875 億美元。歐洲市場呈現穩定成長態勢，預計到 2026 年，英國市場規模將達到 3,340 萬美元，德國將達到 5,380 萬美元，這主要得益於人口老化和長期住院人數的增加。由於醫藥和醫療器材製造業的快速擴張，亞太地區預計將擁有最高的複合年增長率。到 2026 年，日本預計將達到 5,560 萬美元，中國達到 7,230 萬美元，印度達到 4,180 萬美元。拉丁美洲和中東及非洲地區由於認知度較低，市場佔有率較小。

主要公司與產業趨勢

主要公司包括 3M、STERIS、ASP、Getinge、Mesa Labs、Tuttnauer、Bioquell 和 Terragene。主要趨勢如下：

  • 2022 年 6 月：3M 的 Attest Rapid Readout BI 1295 汽化過氧化氫滅菌器獲得批准。
  • 2022 年 3 月：Tuttnauer 收購了 Prestige Medical Ltd.，擴大了在特定國家的銷售網絡。
  • 2021年12月：Terragene與Keir Surgical Ltd.合作，開始提供蒸氣滅菌的快速讀數生物指示劑。
  • 2021年6月：STERIS收購了Cantel Medical LLC，將Crosstex BI產品線納入其產品組合。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 定價、主要公司
  • 主要地區的滅菌指南
  • 關鍵趨勢：併購、業務合作等
  • 新冠疫情對市場的影響

第五章 全球蒸氣與過氧化氫滅菌生物指示劑市場分析：洞察與預測 （2021-2034）

  • 市場收入與規模（千單位）分析、洞察與預測：依產品類型劃分
    • 獨立式小瓶
    • 孢子條
    • 孢子懸浮液
  • 市場收入與規模（千單位）分析、洞察與預測：依應用領域劃分
    • 製藥和醫療器材製造商
    • 醫療機構
    • 其他
  • 市場收入與規模（千單位）分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美蒸氣與過氧化氫滅菌用生物指示劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲蒸氣與過氧化氫滅菌生物指示劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 義大利
    • 法國
    • 俄羅斯
    • 其他歐洲國家

第八章 亞太地區蒸氣與過氧化氫滅菌生物指示劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 南亞國家韓國
    • 東南亞
    • 其他亞太地區

第九章 拉丁美洲蒸氣與過氧化氫滅菌生物指示劑市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家

第10章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • 3M
    • Mesa Labs, Inc.
    • Terragene
    • Ecolab
    • STERIS
    • Liofilchem S.r.l.
    • GKE-GmbH
    • Getinge
    • Tuttnauer
    • Etigam bv
    • Shanghai Fuze Medicine Equipment Co., Ltd.
    • Zhejiang TAILIN Bioengineering Co., LTD
    • SKAN AG
Product Code: FBI105204

Growth Factors of steam and hydrogen peroxide biological indicators Market

The global steam and hydrogen peroxide biological indicators market was valued at USD 803.76 million in 2025 and is projected to grow to USD 865.02 million in 2026, reaching USD 1,644.03 million by 2034, exhibiting a CAGR of 8.36% from 2026 to 2034. North America led the global market in 2025 with a 34.90% share, driven by stringent infection control regulations, growing surgical volumes, and rapid adoption of sterilization monitoring protocols across healthcare and pharmaceutical sectors. The U.S. market is expected to reach USD 387.7 million by 2030, owing to rising surgical site infections and increased focus on sterilization in hospitals and dental clinics.

Market Overview and Product Insights

Biological indicators (BIs) provide a direct measure of sterilization effectiveness, ensuring reliable monitoring in processes using steam, hydrogen peroxide, ethylene oxide, and other sterilizing agents. The increasing emphasis on sterilization in healthcare facilities, pharmaceutical, biotechnology, and food industries drives market growth. Regulatory standards enforcing contamination prevention, combined with new product launches, have further accelerated the adoption of steam and hydrogen peroxide biological indicators.

Among product types, self-contained vials (SCBIs) hold the largest share due to their high reliability, ease of use, and rapid results. In 2026, the self-contained vials segment accounted for 67.33% of the market, valued at USD 582.4 million, driven by higher adoption in both developed and emerging healthcare markets. Spore strips hold the second-largest share due to their lower cost and suitability for smaller clinics and healthcare facilities. Spore-suspension indicators are also used but represent a smaller market segment.

Application Insights

By application, healthcare facilities dominate, accounting for 72.26% of the global market in 2026, valued at USD 625.1 million. The rise in hospital-acquired infections (HAIs) and the growing number of surgical procedures necessitate routine sterilization monitoring. Pharmaceutical and medical device companies hold the second-largest share, as stringent sterilization requirements prevent contamination and product recalls, emphasizing the importance of biological indicators in production workflows.

COVID-19 Impact

The COVID-19 pandemic accelerated demand for sterilization and disinfectant monitoring products. Hospitals, dental clinics, and pharmaceutical companies increased sterilization measures to avoid viral or bacterial HAIs. For example, 3M's medical solutions division reported a 25.9% revenue increase in 2020, reflecting the heightened demand for BIs during the pandemic. While post-pandemic growth normalized, the long-term demand remains strong due to ongoing surgical procedures and heightened infection control protocols.

Market Trends

The market is witnessing a shift toward rapid biological indicators, offering faster results than conventional products. Traditional indicators require 72-168 hours for incubation, whereas rapid BIs provide results in minutes. Regulatory approvals, such as the U.S. FDA approval of the Sterrad Velocity Biological Indicator in January 2020, support this trend, increasing adoption across pharmaceutical and medical device manufacturing.

Market Growth Factors

Rising surgical volumes, increasing prevalence of chronic diseases, and higher healthcare expenditure drive the need for sterile medical instruments. Globally, approximately 313 million surgeries are performed annually, according to the WHO. This creates significant demand for monitoring devices, including steam and hydrogen peroxide biological indicators. Product innovations, such as STERIS Spordex SCBI Ampoules launched in December 2020, further enhance market growth.

Restraining Factors

The adoption of BIs faces competition from alternate solutions like enzyme indicators, which offer faster results, ease of use, and lower costs. The high cost of BIs also limits widespread adoption, particularly in developing regions. For instance, the FDA approved Instant 20s Enzymatic Indicator by True Indicating LLC in December 2021, capable of monitoring steam sterilization processes rapidly, challenging traditional BIs.

Regional Insights

North America led in 2025 with USD 280.9 million, and the U.S. market is projected at USD 287.5 million by 2026. Europe shows steady growth, with the UK reaching USD 33.4 million and Germany USD 53.8 million by 2026, driven by geriatric populations and longer hospital stays. Asia Pacific is expected to witness the highest CAGR due to rapid expansion of pharmaceutical and medical device manufacturing, with Japan at USD 55.6 million, China at USD 72.3 million, and India at USD 41.8 million by 2026. Latin America and the Middle East & Africa account for smaller shares due to lower awareness.

Key Players and Industry Developments

Major players include 3M, STERIS, ASP, Getinge, Mesa Labs, Tuttnauer, Bioquell, and Terragene. Notable developments include:

  • June 2022: 3M received approval for Attest Rapid Readout BI 1295 for vaporized hydrogen peroxide sterilization.
  • March 2022: Tuttnauer acquired Prestige Medical Ltd. to expand distribution in selected countries.
  • December 2021: Terragene partnered with Keir Surgical Ltd. to provide instant-read steam biological indicators.
  • June 2021: STERIS acquired Cantel Medical LLC, adding Crosstex BI products to its portfolio.

Conclusion

The steam and hydrogen peroxide biological indicators market is set for robust growth, expanding from USD 803.76 million in 2025 to USD 1,644.03 million by 2034, driven by increasing surgical procedures, stringent sterilization regulations, and technological innovations in rapid biological indicators. Despite challenges from alternate products and high costs, the ongoing focus on patient safety, HAIs prevention, and sterilization efficiency ensures strong market potential across healthcare and pharmaceutical sectors globally.

Segmentation By Product Type, By Application, and By Geography

By Product Type * Self-contained Vials

  • Spore Strips
  • Spore-suspension

By Application * Pharmaceutical & Medical Device Companies

  • Healthcare Facilities
  • Others

By Geography

North America (By Product Type, By Application, and By Country)

    • U.S.
    • Canada
  • Europe (By Product Type, By Application, and By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, and By Country/Sub-region)
    • Japan
    • China
    • India
    • Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, and By Country/Sub-region)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, and By Country/Sub-region)
    • Turkey
    • Saudi Arabia
    • U.A.E.
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Pricing, Key Players
  • 4.2. Guidelines for Sterilization: Key Region
  • 4.3. Key Mergers, Acquisitions, Partnerships, etc.
  • 4.4. Impact of COVID-19 on the Market

5. Global Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Self-contained Vials
    • 5.1.2. Spore Strips
    • 5.1.3. Spore Suspension
  • 5.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 5.2.1. Pharmaceutical and Medical Device Companies
    • 5.2.2. Healthcare Facilities
    • 5.2.3. Others
  • 5.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Self-contained Vials
    • 6.1.2. Spore Strips
    • 6.1.3. Spore Suspension
  • 6.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 6.2.1. Pharmaceutical and Medical Device Companies
    • 6.2.2. Healthcare Facilities
    • 6.2.3. Others
  • 6.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Self-contained Vials
    • 7.1.2. Spore Strips
    • 7.1.3. Spore Suspension
  • 7.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 7.2.1. Pharmaceutical and Medical Device Companies
    • 7.2.2. Healthcare Facilities
    • 7.2.3. Others
  • 7.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.3.1. Germany
    • 7.3.2. U.K.
    • 7.3.3. Italy
    • 7.3.4. France
    • 7.3.5. Russia
    • 7.3.6. Rest of Europe

8. Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Self-contained Vials
    • 8.1.2. Spore Strips
    • 8.1.3. Spore Suspension
  • 8.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 8.2.1. Pharmaceutical and Medical Device Companies
    • 8.2.2. Healthcare Facilities
    • 8.2.3. Others
  • 8.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. South Korea
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Steam and Hydrogen Peroxide Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Self-contained Vials
    • 9.1.2. Spore Strips
    • 9.1.3. Spore Suspension
  • 9.2. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 9.2.1. Pharmaceutical and Medical Device Companies
    • 9.2.2. Healthcare Facilities
    • 9.2.3. Others
  • 9.3. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Argentina
    • 9.3.4. Rest of Latin America
  • 9.4. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Product Type
    • 9.4.1. Self-contained Vials
    • 9.4.2. Spore Strips
    • 9.4.3. Spore Suspension
  • 9.5. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Application
    • 9.5.1. Pharmaceutical and Medical Device Companies
    • 9.5.2. Healthcare Facilities
    • 9.5.3. Others
  • 9.6. Market Revenue (USD million) and Volume (1,000 Units) Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Turkey
    • 9.6.2. Saudi Arabia
    • 9.6.3. United Arab Emirates (U.A.E)
    • 9.6.4. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 10.2.1. 3M
      • 10.2.1.1. Overview,
      • 10.2.1.2. Products,
      • 10.2.1.3. SWOT Analysis,
      • 10.2.1.4. Recent Developments,
      • 10.2.1.5. Strategies,
      • 10.2.1.6. financials (Based on Availability)
    • 10.2.2. Mesa Labs, Inc.
      • 10.2.2.1. Overview,
      • 10.2.2.2. Products,
      • 10.2.2.3. SWOT Analysis,
      • 10.2.2.4. Recent Developments,
      • 10.2.2.5. Strategies,
      • 10.2.2.6. financials (Based on Availability)
    • 10.2.3. Terragene
      • 10.2.3.1. Overview,
      • 10.2.3.2. Products,
      • 10.2.3.3. SWOT Analysis,
      • 10.2.3.4. Recent Developments,
      • 10.2.3.5. Strategies,
      • 10.2.3.6. financials (Based on Availability)
    • 10.2.4. Ecolab
      • 10.2.4.1. Overview,
      • 10.2.4.2. Products,
      • 10.2.4.3. SWOT Analysis,
      • 10.2.4.4. Recent Developments,
      • 10.2.4.5. Strategies,
      • 10.2.4.6. financials (Based on Availability)
    • 10.2.5. STERIS
      • 10.2.5.1. Overview,
      • 10.2.5.2. Products,
      • 10.2.5.3. SWOT Analysis,
      • 10.2.5.4. Recent Developments,
      • 10.2.5.5. Strategies,
      • 10.2.5.6. financials (Based on Availability)
    • 10.2.6. Liofilchem S.r.l.
      • 10.2.6.1. Overview,
      • 10.2.6.2. Products,
      • 10.2.6.3. SWOT Analysis,
      • 10.2.6.4. Recent Developments,
      • 10.2.6.5. Strategies,
      • 10.2.6.6. financials (Based on Availability)
    • 10.2.7. GKE-GmbH
      • 10.2.7.1. Overview,
      • 10.2.7.2. Products,
      • 10.2.7.3. SWOT Analysis,
      • 10.2.7.4. Recent Developments,
      • 10.2.7.5. Strategies,
      • 10.2.7.6. financials (Based on Availability)
    • 10.2.8. Getinge
      • 10.2.8.1. Overview,
      • 10.2.8.2. Products,
      • 10.2.8.3. SWOT Analysis,
      • 10.2.8.4. Recent Developments,
      • 10.2.8.5. Strategies,
      • 10.2.8.6. financials (Based on Availability)
    • 10.2.9. Tuttnauer
      • 10.2.9.1. Overview,
      • 10.2.9.2. Products,
      • 10.2.9.3. SWOT Analysis,
      • 10.2.9.4. Recent Developments,
      • 10.2.9.5. Strategies,
      • 10.2.9.6. financials (Based on Availability)
    • 10.2.10. Etigam bv
      • 10.2.10.1. Overview,
      • 10.2.10.2. Products,
      • 10.2.10.3. SWOT Analysis,
      • 10.2.10.4. Recent Developments,
      • 10.2.10.5. Strategies,
      • 10.2.10.6. financials (Based on Availability)
    • 10.2.11. Shanghai Fuze Medicine Equipment Co., Ltd.
      • 10.2.11.1. Overview,
      • 10.2.11.2. Products,
      • 10.2.11.3. SWOT Analysis,
      • 10.2.11.4. Recent Developments,
      • 10.2.11.5. Strategies,
      • 10.2.11.6. financials (Based on Availability)
    • 10.2.12. Zhejiang TAILIN Bioengineering Co., LTD
      • 10.2.12.1. Overview,
      • 10.2.12.2. Products,
      • 10.2.12.3. SWOT Analysis,
      • 10.2.12.4. Recent Developments,
      • 10.2.12.5. Strategies,
      • 10.2.12.6. financials (Based on Availability)
    • 10.2.13. SKAN AG
      • 10.2.13.1. Overview,
      • 10.2.13.2. Products,
      • 10.2.13.3. SWOT Analysis,
      • 10.2.13.4. Recent Developments,
      • 10.2.13.5. Strategies,
      • 10.2.13.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 3: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 4: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 5: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Region, 2021-2034
  • Table 6: Global Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Region, 2021-2034
  • Table 7: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 8: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 9: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 10: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 11: North America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country, 2021-2034
  • Table 12: North America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country, 2021-2034
  • Table 13: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 15: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 16: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 17: Europe Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Europe Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 21: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 22: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 27: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 28: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 29: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Product Type, 2021-2034
  • Table 33: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, by Application, 2021-2034
  • Table 34: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Volume (1,000 Units) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Steam and Hydrogen Peroxide Biological Indicators Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
  • Figure 2: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Region, 2025 & 2034
  • Figure 5: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 6: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 7: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 8: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 9: North America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country, 2025 & 2034
  • Figure 10: North America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country, 2025
  • Figure 11: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 12: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 14: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 15: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 20: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 21: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 24: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 26: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 27: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Product Type, 2025 & 2034
  • Figure 30: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), by Application, 2025 & 2034
  • Figure 32: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), by Application, 2025
  • Figure 33: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Steam and Hydrogen Peroxide Biological Indicators Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Steam and Hydrogen Peroxide Biological Indicators Market Share (%), By Company, 2025